lung cancer VLP immunotherapeutic vaccine (Agilvax)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namelung cancer VLP immunotherapeutic vaccine (Agilvax)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAgilvax
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAgilvax
Active IndicationsN/A
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A